Recurrent pembrolizumab-induced mechanical small bowel obstruction in a patient with metastatic cervical cancer

Recurrent pembrolizumab-induced mechanical small bowel obstruction in a patient with metastatic cervical cancer

Bibliographic Details
Main Authors:	Sha Sha, Evan R. J. Goyette, Loyd A. West, Jessica L. Bentz
Format:	Article
Language:	English
Published:	Elsevier 2024-06-01
Series:	Gynecologic Oncology Reports
Subjects:	Pembrolizumab Cervical cancer Recurrent small bowel obstruction Checkpoint immunotherapy Immune-mediated adverse events
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352578924000614

Similar Items

Real-World Experience of Pembrolizumab Monotherapy in Patients with Recurrent or Persistent Cervical Cancer: A Korean Multi-Center Retrospective Study (KGOG1041)
by: Min Chul Choi, et al.
Published: (2020-10-01)

Severe hematuria in a patient receiving bevacizumab and pembrolizumab for metastatic cervical cancer: a case report
by: Yanxin Liu, et al.
Published: (2023-03-01)

Case report: Clinical experience of treating pembrolizumab-induced systemic capillary leak syndrome (SCLS) in one patient with metastatic gastroesophageal junction squamous cell carcinoma
by: Hua Ni, et al.
Published: (2023-09-01)

Pembrolizumab-induced myocarditis with complete atrioventricular block and concomitant myositis in a metastatic bladder cancer patient: a case report and review of the literature
by: R. Saad, et al.
Published: (2024-02-01)

Early development of pembrolizumab‐induced fulminant myositis and cardiotoxicity in a patient with metastatic thymoma
by: Soo Yeon Jang, et al.
Published: (2022-09-01)

Real-world efficacy and safety of low-dose pembrolizumab in patients with advanced and refractory gynecologic cancers
by: Chien-Hsiang Kao, et al.
Published: (2024-04-01)

Comparative cost-effectiveness of first-line pembrolizumab plus chemotherapy vs. chemotherapy alone in persistent, recurrent, or metastatic cervical cancer
by: Ying-tao Lin, et al.
Published: (2024-01-01)

Pembrolizumab-Related Side Effects: Acute Renal Failure and Severe Neurological Toxicity
by: Gabriele Fasano, et al.
Published: (2022-01-01)

Hemophagocytic lymphohistiocytosis following pembrolizumab and bevacizumab combination therapy for cervical cancer: a case report and systematic review
by: Chongya Zhai, et al.
Published: (2024-01-01)

Anterior Uveitis Secondary to Avelumab and Pembrolizumab in a Patient with Metastatic Renal Cell Carcinoma—A Case Report
by: Wei-Lun Chu, et al.
Published: (2024-03-01)

Public Adverse Event Data Insights into the Safety of Pembrolizumab in Melanoma Patients
by: Anne Schaefer, et al.
Published: (2020-04-01)

Complete response to pembrolizumab for metastatic urothelial carcinoma in the renal pelvis of allograft kidney
by: Jun Kamei, et al.
Published: (2022-05-01)

Objective Responses in Metastatic Pleomorphic Rhabdomyosarcoma Treated with Combination of Doxorubicin and Pembrolizumab: A Case Series
by: Ioannis Kournoutas, et al.
Published: (2024-02-01)

Toxicity Associated with Immune Checkpoint Inhibitors: Analysis of Immune-Related Adverse Events with a Pembrolizumab Biosimilar (Pembroria)
by: M. Yu. Fedyanin, et al.
Published: (2023-06-01)

Pembrolizumab Induced Sclerosing Cholangitis: Why You Need a Liver Biopsy
by: Ian Liang, et al.
Published: (2023-03-01)

A Case of Metastatic Melanoma Presenting as a Small Bowel Obstruction
by: Danielle Harris, et al.
Published: (2022-07-01)

Molecular Farming of Pembrolizumab and Nivolumab
by: Michael C. Stark, et al.
Published: (2023-06-01)

Very Delayed Acute Hepatitis after Pembrolizumab Therapy for Advanced Malignancy: How Long Should We Watch?
by: Timothy Phan, et al.
Published: (2021-02-01)

Real-World Data Analysis of Pembrolizumab Monotherapy for NSCLC Using Japanese Postmarketing All-Case Surveillance Data
by: Hideki Terai, MD, et al.
Published: (2022-11-01)

mechanical small bowel obstruction
by: munthir Al-Obaidi
Published: (2007-01-01)

Tough Decision Making in Pembrolizumab-Associated Acute Interstitial Nephritis: A Case Report
by: João Grilo, et al.
Published: (2023-06-01)

Efficacy and safety of pembrolizumab on cervical cancer: A systematic review and single-arm meta-analysis
by: Lin Qi, et al.
Published: (2022-08-01)

Case Report: Immune Checkpoint Inhibitors as a Single Agent in the Treatment of Metastatic Cervical Cancer
by: Manasa Anipindi, et al.
Published: (2022-04-01)

PEMBROLIZUMAB IN THE TREATMENT OF METASTATIC MELANOMA
by: I. V. SAMOILENKO, et al.
Published: (2017-06-01)

Case Report: Long-term metabolic response of metastatic uveal melanoma to pembrolizumab on FDG-PET/CT despite a serial pseudoprogressions phenomenon
by: Karim Amrane, et al.
Published: (2023-12-01)

Pembrolizumab induced remission of recurrent and metastatic sinonasal squamous cell carcinoma after overcoming checkpoint‐inhibitor pneumonitis: A case report and literature review
by: Deepak Rajendran Nair, et al.
Published: (2023-07-01)

The clinical outcome of pembrolizumab for patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a single center, real world study in China
by: Zongyu Fan, et al.
Published: (2024-02-01)

Intussusception as a cause of bowel obstruction in adults
by: C Toso, et al.
Published: (2005-02-01)

Sclerosing Mesenteritis: A Rare Cause of Small Bowel Obstruction
by: Glenn Harvin, et al.
Published: (2016-04-01)

Case report: Pembrolizumab as an alternative to atezolizumab following a severe infusion reaction
by: Seung Hyuk Lee, et al.
Published: (2024-03-01)

A nomogram for predicting the recurrence of small bowel obstruction after gastrectomy in patients with gastric cancer
by: Wenhao Yu, et al.
Published: (2023-11-01)

Elective adhesiolysis for chronic abdominal pain reduces long-term risk of adhesive small bowel obstruction
by: Barend A. W. van den Beukel, et al.
Published: (2023-01-01)

Regression of cutaneous squamous cell carcinoma after the development of pembrolizumab‐induced bullous pemphigoid
by: Shin Iinuma, et al.
Published: (2023-03-01)

Case report: A rare case of neutropenia caused by pembrolizumab in squamous lung cancer and literature review
by: Qiaoyun Tan, et al.
Published: (2022-11-01)

Malignant Bowel Obstruction in Ovarian Cancer Recurrence: The Role of Palliative Surgery in a Decision-Making Process
by: Eugenia De Crescenzo, et al.
Published: (2022-07-01)

Ultrasound of Small Bowel Obstruction: A Pictorial Review
by: Nicola Rosano, et al.
Published: (2021-03-01)

Ultrasound Signs in the Diagnosis and Staging of Small Bowel Obstruction
by: Stefania Tamburrini, et al.
Published: (2020-05-01)

An immune-related adverse event of Behcet’s-like syndrome following pembrolizumab treatment
by: Qiao Chen, et al.
Published: (2024-04-01)

Pancreatitis as immune‐related adverse event during pembrolizumab therapy for multiple lung metastases from renal pelvic cancer
by: Kazuki Kokura, et al.
Published: (2023-11-01)

Clinical course and management of insidious adrenal crisis manifested initially as hyperpyrexia secondary to pembrolizumab: Case reports and literature review
by: Dandan Geng, et al.
Published: (2022-08-01)